California Law Expanded HIV Prevention Access
New legislation ensures injectable HIV prevention is covered through pharmacy benefits starting in 2027.
Updated on Sept. 29, 2026 in COVID-19
Live Poll
Should insurance companies be required to cover preventative medications through both medical and pharmacy benefits?
Governor Gavin Newsom has signed Senate Bill 1023, a measure designed to broaden access to long-acting injectable HIV pre-exposure prophylaxis (PrEP) throughout California. The law mandates that health insurers cover these injections through standard outpatient prescription benefits.
Why it matters
By removing administrative hurdles, the law aims to lower financial barriers for community clinics and smaller healthcare providers. This change addresses longstanding difficulties in obtaining reimbursement for injectable medications that were previously processed through complex medical billing pathways.
This legislative change standardizes reimbursement protocols for long-acting injectable PrEP, which is administered once every six months. The requirement addresses an administrative gap affecting clinics and providers, though the specific impact on total statewide uptake remains unknown.
The players
Gavin Newsom
The Governor of California who signed Senate Bill 1023 into law.
California Legislative LGBTQ Caucus
A group of state lawmakers who prioritized the passage of this legislation.
California Department of Insurance
The state agency that co-sponsored the legislation to standardize insurance coverage.
The details
Injectable PrEP is a prophylactic medication administered by a healthcare professional every six months. Previously, many health plans required providers to use medical benefit billing, which often forced clinics to purchase the drug upfront and employ specialized staff to handle reimbursement. The new law shifts this process to the standard outpatient prescription drug benefit pathway, simplifying operations for smaller practices.
Timeline
Jan. 1, 2027: The new law takes effect.
Health Landscape
Senate Bill 1023 represents a structural shift in how California addresses HIV prevention by aligning payment models with the evolving nature of long-acting therapeutics. This move aligns with broader efforts to modernize preventative care access by lowering administrative burdens for local clinicians.
If you are interested in long-acting injectable PrEP, talk to your doctor about whether this preventative option is appropriate for your health needs. While the new coverage rules take effect in 2027, you can discuss current insurance coverage and administration options with your provider today.
The takeaway
Senate Bill 1023 simplifies the reimbursement process for injectable HIV prevention starting in 2027. Patients should consult with their healthcare team to understand their current coverage options and how upcoming policy changes may influence their access to long-acting preventative treatments.
Further reading
Learn more about the latest developments in viral disease management in the California COVID-19 section.
More information
Review the full text of the bill on the California legislative information portal.
Source note: This article includes information reported by Paso Robles Daily News.
Live Poll
Should insurance companies be required to cover preventative medications through both medical and pharmacy benefits?
